Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | -1.19 | -1.75 | -3.26 | -4.96 |
Depreciation/ Depletion | 0.57 | 0.63 | 0.66 | 0.67 |
Deferred Taxes | 0.89 | 5.56 | 10.79 | 9.69 |
Non- Cash Items | 0.01 | -0.01 | -0.01 | -0.01 |
Changesin Working Capital | 0.69 | 1.77 | 0.53 | 4.45 |
Cashfrom Operating Activities | 0.17 | 1.20 | -1.01 | 1.11 |
Capital Expenditures | 0.00 | -0.03 | -0.06 | -0.09 |
Other Investing Cash Flow Items Total | 0.05 | 0.01 | -0.03 | 0.03 |
Cashfrom Investing Activities | 0.05 | -0.02 | -0.09 | -0.06 |
Financing Cash Flow Items | -0.37 | -1.50 | -1.48 | -1.63 |
Issuance( Retirement)of Debt Net | 0.17 | 0.32 | 2.58 | 0.54 |
Cashfrom Financing Activities | -0.20 | -1.18 | 1.10 | -1.09 |
Net Changein Cash | 0.02 | 0.00 | 0.00 | -0.04 |
Cash Interest Paid | 0.37 | 1.50 | 1.48 | 1.63 |
Norris Medicines Dividend Norris Medicines Bonus Norris Medicines News Norris Medicines AGM Norris Medicines Rights Norris Medicines Splits Norris Medicines Board Meetings Norris Medicines Key Metrics Norris Medicines Shareholdings Norris Medicines Profit Loss Norris Medicines Balance Sheet Norris Medicines Q1 Results Norris Medicines Q2 Results Norris Medicines Q3 Results Norris Medicines Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks